盘龙药业
(002864)
| 流通市值：22.46亿 | | | 总市值：32.39亿 |
| 流通股本：7368.52万 | | | 总股本：1.06亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 222,541,696.37 | 1,140,869,253.68 | 841,452,392.85 | 574,023,000.14 |
| 营业收入 | 222,541,696.37 | 1,140,869,253.68 | 841,452,392.85 | 574,023,000.14 |
| 二、营业总成本 | 189,458,728.35 | 1,018,736,848.08 | 735,238,373.82 | 502,134,108.31 |
| 营业成本 | 100,468,878.56 | 549,079,773.94 | 398,130,242.64 | 280,795,329.78 |
| 税金及附加 | 2,677,575.23 | 12,287,298.89 | 8,717,179.22 | 5,814,253.63 |
| 销售费用 | 72,016,982.02 | 349,241,153.18 | 271,151,667.7 | 181,091,647.12 |
| 管理费用 | 12,620,207.64 | 67,317,756.91 | 45,830,797.56 | 30,440,491.49 |
| 研发费用 | 3,420,187.2 | 53,111,026.11 | 24,095,842.41 | 15,850,091.6 |
| 财务费用 | -1,745,102.3 | -12,300,160.95 | -12,687,355.71 | -11,857,705.31 |
| 其中:利息费用 | 506,354.09 | 2,184,131.7 | 2,389,236.85 | 1,518,547.12 |
| 其中:利息收入 | 2,261,312.31 | 14,550,611.61 | 15,130,141.83 | 13,415,920.16 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -56,018.01 | -133,892.42 | -174,193.12 | -119,497.29 |
| 资产处置收益 | -113.73 | 129,512.89 | 129,676.24 | -10,511.53 |
| 资产减值损失(新) | -133,966.01 | -165,178.65 | -211,235.57 | -187,608.28 |
| 信用减值损失(新) | -1,799,525.72 | -24,288,732.57 | -7,348,593.36 | -9,173,057.09 |
| 其他收益 | 4,306,965.19 | 12,446,507.58 | 9,329,693.65 | 8,264,779.16 |
| 四、营业利润 | 35,400,309.74 | 110,120,622.43 | 107,939,366.87 | 70,662,996.8 |
| 加:营业外收入 | 330 | 179,184.77 | 73,447.75 | 54,604.7 |
| 减:营业外支出 | 1,810,200.49 | 1,348,129.04 | 1,303,573.32 | 656,224.97 |
| 五、利润总额 | 33,590,439.25 | 108,951,678.16 | 106,709,241.3 | 70,061,376.53 |
| 减:所得税费用 | 11,855,160.85 | 12,930,129.47 | 17,106,813.44 | 10,081,903.02 |
| 六、净利润 | 21,735,278.4 | 96,021,548.69 | 89,602,427.86 | 59,979,473.51 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 21,735,278.4 | 96,021,548.69 | 89,602,427.86 | 59,979,473.51 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 21,760,948.7 | 96,279,404.46 | 89,805,874.28 | 60,135,150.47 |
| 少数股东损益 | -25,670.3 | -257,855.77 | -203,446.42 | -155,676.96 |
| 扣除非经常损益后的净利润 | 20,014,169.48 | 86,753,851.96 | 82,470,089.55 | 52,857,463.86 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.92 | 0.85 | 0.57 |
| (二)稀释每股收益 | 0.21 | 0.92 | 0.85 | 0.57 |
| 九、综合收益总额 | 21,735,278.4 | 96,021,548.69 | 89,602,427.86 | 59,979,473.51 |
| 归属于母公司股东的综合收益总额 | 21,760,948.7 | 96,279,404.46 | 89,805,874.28 | 60,135,150.47 |
| 归属于少数股东的综合收益总额 | -25,670.3 | -257,855.77 | -203,446.42 | -155,676.96 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-28 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |